Novartis AG vs Otis Worldwide Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Otis Worldwide Corp trades at $72.17 (market cap $28.20B). The key difference: Novartis AG is far larger — about 10.3× Otis Worldwide Corp's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | OTIS | |
|---|---|---|
Market Cap | $290.25B | $28.20B |
Sector | Health | Industrials |
52-Week High | $168.62 | $100.99 |
52-Week Low | $113.50 | $69.34 |
Enterprise Value | $330.27B | $35.58B |
Dividend Yield | 3.17% | 2.31% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →